The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes.
(Q44909546)
scientific article
scientific article
Language:
Current Data About
The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes.
other details
description | scientific article |
External Links
(P356) |
10.2337/DIACARE.27.6.1394
|
(P698) |
15161794
|
(P5875) |
8544263
|
(P8608) |
release_cphljooltbglle2l4swpozhiga
|